ClinicalTrials.gov
public full text
Public Domain
Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host
By obtaining clinical specimens from participants with triple negative breast cancer (TNBC), colorectal cancer (CRC), high grade serous ovarian cancer (HGSOC), and other select tumor types to establish and profile as freshly implanted tumors in mice, the aim of this study is to identify agents with predicted activity in the host patient while also potentially providing them with personalized cancer treatment options
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A pan-cancer, pan-treatment model for predicting drug responses from patient-derived xenografts#222001
- OpenTumorBoard: A Real-World Benchmark of Multidisciplinary Tumor Board Discussion Trajectories#1117141
- Onco4D(TM) Biodynamic Chemotherapy Selection for Bladder Cancer Patients#1045144
- Establishing Organoids From Metastatic Pancreatic Cancer Patients, the OPT-I Study.#1094444
- Multi-layer molecular profiling defines an immune-active colorectal cancer subtype with therapeutic relevance.#4406
Record · ID 968257
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive